Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-01-000306
Filing Date
2001-02-23
Accepted
2001-02-23 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 0001.txt SC 13G 8797
  Complete submission text file 0000919574-01-000306.txt   10750
Mailing Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 1010017
Business Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 10017 2128082400
CURRAN JOHN P (Filed by) CIK: 0000026256 (see all company filings)

 

Mailing Address 425 WOODSMILL RD ST LOUIS MO 63017
Business Address 425 WOODSMILL RD ST LOUIS MO 63017 3145799899
SHEFFIELD PHARMACEUTICALS INC (Subject) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50777 | Film No.: 1552608
SIC: 2834 Pharmaceutical Preparations